Practice
Featured experience
InSilico Medicine HK$2.62 billion IPO
We advised InSilico Medicine on its IPO and HKEX listing
Mastercard $1.8 billion acquisition of BVNK
We are advising Mastercard on the transaction
Sycamore Partners up to $23.7 billion acquisition of Walgreens Boots Alliance
We advised Sycamore Partners on the transaction
Comcast spinoff of select cable television networks
We are advising Comcast on the transaction
Venture Global $1.75 billion IPO
We advised Venture Global on its IPO and NYSE listing
Province of Saskatchewan $1 billion global bond offering
The investment-grade debt is due 2030
Bank of America $10 billion floating-rate and fixed-to-floating-rate notes
The five-tranche investment-grade debt offering is based on the Secured Overnight Financing Rate
Ascentage Pharma $126.4 million IPO
The IPO is the first life sciences U.S. IPO of 2025 and the first life sciences company listed on the HKEX to complete a U.S…
PAR Technology $115 million convertible senior notes offering
The notes are due 2030
Central American Bank for Economic Integration $1.5 billion notes
The notes are due 2028
Emerson $7.2 billion acquisition of remaining outstanding shares of AspenTech
We are advising Emerson on its acquisition
InVue sale to ASSA ABLOY
We advised InVue on the transaction
Ferrero Group acquisition of Power Crunch
We are advising Ferrero on the transaction
Norwegian Cruise Line $1.8 billion senior notes offering
The high-yield notes are due 2032